tradingkey.logo
tradingkey.logo
Search

Neurocrine Biosciences Begins Phase 1 Study of NBIP-01435, a Long-Acting Corticotropin-Releasing Factor Type 1 Receptor Antagonist

ReutersJun 30, 2025 8:41 PM
facebooktwitterlinkedin

- Neurocrine Biosciences Inc NBIX.O:

  • NEUROCRINE BIOSCIENCES ANNOUNCES INITIATION OF PHASE 1 CLINICAL STUDY EVALUATING NBIP-01435, A LONG-ACTING CORTICOTROPIN-RELEASING FACTOR TYPE 1 RECEPTOR ANTAGONIST

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Recommended Articles

Tradingkey
KeyAI